Veru Inc. (NASDAQ:VERU) has entered into a clinical supply agreement with Novo Nordisk A/S (NYSE:NVO) to support its upcoming Phase 2b PLATEAU study, which will investigate a combination treatment for ...

Please note that this event is being recorded. I would now like to turn the conference over to Mr. Sam Fisch, Veru Inc.'s Executive Director, Investor Relations and Corporate Communications. Please go ...

Veru Inc (NASDAQ:VERU) has completed a positive Phase IIb clinical trial demonstrating that their drug, enovasarm, combined with a GLP-1 receptor agonist, preserves lean mass and enhances fat loss in ...

What does Kerala’s living heritage look like? ‘Veru’, an exhibition that opens at David Hall, Fort Kochi, on May 2, showcases the many layers of Kerala’s regional heritage through the very people who ...

Veru Inc (NASDAQ:VERU) successfully completed a Phase 2B clinical trial demonstrating that Enovosarm, in combination with GLP-1 receptor agonists, can lead to selective fat loss while preserving lean ...

Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and the emerging psychedelics drug sector. She co-writes The ...

As Miami-based Veru continues development of its enobosarm to prevent muscle wasting in patients being treated for obesity, among other conditions, the biopharma has conducted a survey showing that ...

Jan 27 (Reuters) - Veru (VERU.O), opens new tab said on Monday its experimental drug in combination with Novo Nordisk's (NOVOb.CO), opens new tab weight-loss treatment Wegovy, helped preserve muscle ...

Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and the emerging psychedelics drug sector. She co-writes The ...

In the final episodes of the ID series, Natalia's continued communication with her prior adoptive family wreaks havoc on the DePaul household as they try to help her understand how she's been ...